Search
SOLACI Congress
HomeCONGRESS

CONGRESS

View Category
EuroPCR 2023

EuroPCR 2023

Here are the most important scientific articles of the EuroPCR 2023. If you cannot view the articles, click...
solaci -
Learn More
Events

SOLACI@SCAI Joint Session at SCAI Scientific Sessions 2023

The Latin American Society of Interventional Cardiology will be at SCAI 2023 Scientific Sessions, one of the...
solaci -
Learn More
Institutional News

Welcome to SOLACI-SBHCI 2023 | August 2-4 2023, Rio de Janeiro

MD Helio Roque Figueira, President of SOLACI-SBHCI 2023, is inviting the entire Latin American interventionist community to...
solaci -
Learn More
Events

Structural Summit SBHCI 2023: Structural heart Intervention Frontier

The Latin American Society of Interventional Cardiology is inviting the medical community to take part of the...
solaci -
Learn More
Events

The EuroPCR 2023 is coming

EuroPCR 2023, one of the most important events in interventional cardiology, will be held in Paris, France,...
solaci -
Learn More
Other

ACC 2023 | COORDINATE-DIABETES

Approximately only 2.7% of all diabetic patients with ischemic heart disease in the United States receive optimal...
solaci -
Learn More
Other

ACC 2023 | A DUE-Study (Phase III)

In pulmonary hypertension (PHT), 10 mg macitentan plus 40 mg tadalafil is recommended as a safe combination therapy for...
solaci -
Learn More
Acute coronary syndromes

ACC 2023 | Ultrasensitive Troponin I Monitoring with a Transdermal Wrist Device

Over the years, early diagnosis of myocardial ischemia has ranged from 0-to-3-h protocols to abbreviated guidelines with...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Perforation Management in Bifurcations: Bench Testing of Bailout with Covered Stents

Dr. Omar Tupayachi - 0
Coronary perforations during PCI are one of the most dreaded complications in interventional cardiology, especially in bifurcations. Though rate, this critical situation requires an...

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Dr. Omar Tupayachi - 0
Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy